New Operating Margin from 2010 to 2026

BBAL Stock  USD 0.0001  0.00  0.00%   
New York Operating Profit Margin yearly trend continues to be quite stable with very little volatility. The value of Operating Profit Margin is projected to decrease to 0.02.
Check New York financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among New York's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 10.2 M or Total Revenue of 44.6 M, as well as many indicators such as Price To Sales Ratio of 0.0454, Dividend Yield of 0.0015 or Days Sales Outstanding of 87.7. New financial statements analysis is a perfect complement when working with New York Valuation or Volatility modules.
  
Build AI portfolio with New Stock
Check out the analysis of New York Correlation against competitors.
Historical Operating Margin data for New York serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether New York Health represents a compelling investment opportunity.

Latest New York's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of New York Health over the last few years. It is New York's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in New York's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (0.02) %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

New Operating Margin Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation39.33
Mean Deviation0.01
Median0.03
Standard Deviation0.01
Sample Variance0.0001
Range0.0518
R-Value(0.46)
Mean Square Error0.0001
R-Squared0.21
Significance0.07
Slope(0)
Total Sum of Squares0

New Operating Margin History

2026 0.0235
2025 0.0247
2011 0.0275
2010 0.0753

About New York Financial Statements

New York investors utilize fundamental indicators, such as Operating Margin, to predict how New Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
New York Health Care, Inc. operates as a home care services agency primarily in New York. The company was founded in 1983 and is based in Valley Stream, New York. New York operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1460 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether New York Health is a strong investment it is important to analyze New York's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact New York's future performance. For an informed investment choice regarding New Stock, refer to the following important reports:
Check out the analysis of New York Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Revenue Per Share
1.365
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0364
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.